Judith Harron

Company: PhRMA

Job title: Assistent General Counsel

Seminars:

Explaining Inflation Reduction Act Generally, the Negotiation Process, and Potential Interactions with Obesity & CVRM Therapeutics 11:30 am

Outlining the key provisions of the Inflation Reduction Act guidelines related to drug pricing negotiations Emphasizing the impact on existing and future drugs to gain a comprehensive understanding of how this can affect pharmaceutical manufacturers with obesity & CVRM portfolio assets as well as other innovative productsRead more

day: Conference Day Two

Panel Discussion: Examining the Potential for the Treat and Reduce Obesity Act to be Passed and the Implications of this Act on Market Access 12:00 pm

Analysing the potential impact of TROA on market access for AOMs and how expanded Medicare coverage could influence private payer behaviour Discussing the challenges of estimating the budgetary impact of the TROA, considering utilization rates, drug pricing and long-term cost savings associated with obesity reduction Understanding how the TROA could impact the pharmaceutical industry’s investment…Read more

day: Conference Day Two